跳至主要内容
临床试验/NCT03857646
NCT03857646已完成4 期

The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2019年3月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
66
试验地点
1
主要终点
Free Bilirubin (UB) Serum Levels

研究概览

简要总结

The goal of this research study is to compare the levels of free fatty acids and free bilirubin between two intravenous lipid emulsion products in premature newborns.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
0 Days 至 8 Days(Child)
性别
All
接受健康志愿者

入选标准

  • premature newborns (<32 weeks gestation, stratified <28 weeks versus >28 weeks) <8 days of age
  • receiving lipid infusions <1 g/kg/day at enrollment
  • anticipated to be treated with 3 g/kg/day for a minimum of 48 hours.

排除标准

  • patients with direct hyperbilirubinemia >1.5 mg/dl
  • with suspected sepsis meeting Systemic inflammatory response syndrome (SIRS) criteria
  • undergoing treatment with a continuous infusion of morphine
  • with a continuous infusion of pressors (dopamine, dobutamine, epinephrine, etc.)
  • positive blood cultures

研究组 & 干预措施

Intralipid

Other

干预措施: Intralipid, 20% Intravenous Emulsion (Drug)

Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipid

Other

干预措施: Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipid (Drug)

结局指标

主要结局

Free Bilirubin (UB) Serum Levels

时间窗: second day of infusion at 3 g/kg/day

次要结局

  • Free Fatty Acid (Total) Serum Level(second day of infusion at 3 g/kg/day)
  • Unbound Free Fatty Acid (FFAu) Serum Level(second day of infusion at 3 g/kg/day)
  • Number of Participants With Direct Bilirubin >1.8 Milligrams Per Deciliter (mg/dL)(first and/or second days of infusion at 3 g/kg/day)
  • Number of Participants With Peak Serum Triglyceride Level >350 mg/dl(first or second days of infusion at 3 g/kg/day)
  • Mean Serum Triglyceride Level(second day of infusion at 3 g/kg/day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Meredith Collins

Physician

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验